DrugPatentWatch Database Preview
Hikal Company Profile
» See Plans and Pricing
What is the competitive landscape for HIKAL, and what generic and branded alternatives to HIKAL drugs are available?
HIKAL has one approved drug.
Summary for Hikal
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Hikal
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikal | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-005 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikal | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-001 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikal | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-008 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikal | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-002 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikal | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-006 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikal | PREGABALIN | pregabalin | CAPSULE;ORAL | 213423-004 | Mar 23, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
